IGC Pharma
29 hedge funds and large institutions have $1.73M invested in IGC Pharma in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.87% less ownership
Funds ownership: 8.2% → 6.33% (-1.9%)
56% less capital invested
Capital invested by funds: $3.97M → $1.73M (-$2.24M)
Holders
29
Holding in Top 10
–
Calls
$236K
Puts
$53K
Top Buyers
1 | +$115K | |
2 | +$63.7K | |
3 | +$30.8K | |
4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$26K |
5 |
Jane Street
New York
|
+$19.5K |
Top Sellers
1 | -$1.31M | |
2 | -$60.7K | |
3 | -$14K | |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
5 |
FFA
Fairfield Financial Advisors
Wellesley,
Massachusetts
|
-$474 |